Comparison of99mTc(V)-DMSA,201Tl and99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid
- 1 October 1996
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 23 (10) , 1367-1371
- https://doi.org/10.1007/bf01367593
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Comparison of 201Tl, 99Tcm-MIBI and 131I imaging in the follow-up of patients with well-differentiated thyroid carcinomaNuclear Medicine Communications, 1996
- Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapy.Journal of Clinical Endocrinology & Metabolism, 1993
- Tc-99m Sestamibi and Other Agents in the Detection of Metastatic Medullary Carcinoma of the ThyroidClinical Nuclear Medicine, 1993
- Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylnitrile scintigraphy: a case report.1991
- PENTAVALENT [TC-99M]DMSA, [I-131]MIBG, AND [TC-99M]MDP-AN EVALUATION OF 3 IMAGING TECHNIQUES IN PATIENTS WITH MEDULLARY CARCINOMA OF THE THYROID1988
- Advances in the Diagnosis and Treatment of Medullary Thyroid CarcinomaSurgical Clinics of North America, 1987
- RECURRENT MEDULLARY CARCINOMA OF THE THYROID DEMONSTRATED BY TL-201 SCINTIGRAPHY1986
- A new imaging agent for medullary carcinoma of the thyroid.1984